Our goal was to determine whether genetic variability in three candidate phospholipase-related genes, namely PLA2G7, SCARB1 and PLA2G4A, was associated with atherosclerosis and the occurrence of CV events in a population of nephrosclerosis patients. This evidence concerns the gene PLA2G4A and atherosclerosis.